Relevea Pain Relief Patch

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Relevea Pain Relief Patch
Generic name
LIDOCAINE 4%
Manufacturer
Links Medical Products
Product type
HUMAN OTC DRUG
SPL set ID
3ce49b85-e9e3-e33c-e063-6294a90a6dbf
SPL ID
5ba14330-677c-454a-e063-6394a90ac0e7
Version
4
Effective date
2026-09-16
Source export date
2026-11-13
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/0ccebc9befe0ec22afe916211b2687f6eef8ed163963720f103786a7f2d2e3ae/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 17:32:20
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS For external use only Do not use more than 1 patch at a time on wounds or damaged skin with a heating pad if you are allergic to any ingredients of this product When using this product use only as directed avoid contact with the eyes, mucous membranes or rashes do not bandage Stop use and ask a doctor if localized skin reactions such as rash, itching, redness, irritation, pain, swelling and blistering occur, conditions worsen, symptoms persist for more than 7 days, or symptoms clear up and occur again within a few days. If pregnant or breast feeding, ask a health professional before use. Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.